Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis.

Gerd R BurmesterLaura C CoatesStanley B CohenYoshiya TanakaIvana VranicEdward NagyIrina LazariciuAll-Shine ChenKenneth KwokLara FallonCassandra D Kinch

Published in: Rheumatology and therapy (2023)

Keyphrases

rheumatoid arthritis
disease activity
public health
ankylosing spondylitis
interstitial lung disease
systemic sclerosis